People in the United States who have HIV and need kidney or liver transplants can now receive organs from donors who also ...

Concerns have been raised by senior doctors surrounding the misuse of weight-loss pens in the UK, with some patients ...

Fluidx Medical Technology, Inc. announced that the first patient has been treated in the prospective, multinational, clinical ...

Winrevair lowered death or transplant risk in adults with PAH functional class 3-4 at high risk of dying; all in study may ...

Widetrial is supporting an expanded access program (EAP) to bring MN-166 (ibudilast) to ALS patients ineligible for clinical ...

Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced ...

Metformin appears to help boost the benefits of immunotherapy drugs used to fight lung tumors, according to a team led by Dr.

WEDNESDAY, Nov. 27, 2024 (HealthDay News) -- The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found. Zepbound reduced the ...

BriaCell Therapeutics (TSE:BCT) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium ...

Just make new data, says a leading academic. But is it as simple as that? In my previous reports on the challenges of using ...

Cloud-enabled integrated diagnostics portfolio aims to unify workflows, improve access to critical insights, and drive better ...

Based on the positive findings from the Phase 1/2 study, Genethon is planning to launch Phase 3 testing of GNT0004 next year.